糖原分解
糖原
生物
糖原磷酸化酶
糖原贮积病
癌变
糖原合酶
磷酸化酶激酶
内分泌学
糖原分支酶
糖原脱支酶
生物化学
内科学
医学
基因
作者
Qingxu Liu,Jiaxin Li,Weiji Zhang,Xiao Chen,Shihao Zhang,Cheng Nian,Junhong Li,Dongxue Su,Lihong Chen,Qian Zhao,Hui Shao,Hao Zhao,Qinghua Chen,Yuxi Li,Jing Geng,Lixin Hong,Shuhai Lin,Qiao Wu,Xianming Deng,Rongqin Ke
出处
期刊:Cell
[Elsevier]
日期:2021-10-01
卷期号:184 (22): 5559-5576.e19
被引量:248
标识
DOI:10.1016/j.cell.2021.10.001
摘要
Glucose consumption is generally increased in tumor cells to support tumor growth. Interestingly, we report that glycogen accumulation is a key initiating oncogenic event during liver malignant transformation. We found that glucose-6-phosphatase (G6PC) catalyzing the last step of glycogenolysis is frequently downregulated to augment glucose storage in pre-malignant cells. Accumulated glycogen undergoes liquid-liquid phase separation, which results in the assembly of the Laforin-Mst1/2 complex and consequently sequesters Hippo kinases Mst1/2 in glycogen liquid droplets to relieve their inhibition on Yap. Moreover, G6PC or another glycogenolysis enzyme-liver glycogen phosphorylase (PYGL) deficiency in both human and mice results in glycogen storage disease along with liver enlargement and tumorigenesis in a Yap-dependent manner. Consistently, elimination of glycogen accumulation abrogates liver growth and cancer incidence, whereas increasing glycogen storage accelerates tumorigenesis. Thus, we concluded that cancer-initiating cells adapt a glycogen storing mode, which blocks Hippo signaling through glycogen phase separation to augment tumor incidence.
科研通智能强力驱动
Strongly Powered by AbleSci AI